BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29191749)

  • 1. Design and verification of halogen-bonding system at the complex interface of human fertilization-related MUP PDZ5 domain with CAMK's C-terminal peptide.
    Wang J; Guo Y; Zhang X
    Comput Biol Chem; 2018 Feb; 72():164-169. PubMed ID: 29191749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design of an orthogonal noncovalent interaction system at the MUPP1 PDZ11 complex interface with CaMKIIα-derived peptides in human fertilization.
    Zhang YL; Han ZF
    Mol Biosyst; 2017 Sep; 13(10):2145-2151. PubMed ID: 28832060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide selectivity between the PDZ domains of human pregnancy-related serine proteases (HtrA1, HtrA2, HtrA3, and HtrA4) can be reshaped by different halogen probes.
    Sun ML; Sun LM; Wang YQ
    J Mol Recognit; 2018 Jun; 31(6):e2698. PubMed ID: 29266444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular design and validation of halogen bonding orthogonal to hydrogen bonding in breast cancer MDM2-peptide complex.
    Huang A; Zhou L; Zhang D; Yao J; Zhang Y
    J Mol Graph Model; 2016 Nov; 70():40-44. PubMed ID: 27649550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based identification of CaMKIIα-interacting MUPP1 PDZ domains and rational design of peptide ligands to target such interaction in human fertilization.
    Zhang YL; Han ZF; Sun YP
    Amino Acids; 2016 Jun; 48(6):1509-21. PubMed ID: 26984442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-Based Design of a Br Halogen Bond at the Complex Interface of the Human Placental HtrA1 PDZ Domain with Its Heptapeptide Ligand.
    Dou SF; Liu H; Cao TM; Wen QL; Li J; Shao QC
    Arch Pharm (Weinheim); 2016 Apr; 349(4):302-7. PubMed ID: 26972470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational derivation of CETP self-binding helical peptides by π-π stacking and halogen bonding: Therapeutic implication for atherosclerosis.
    Zhu J; Lu M; Zhu L
    Bioorg Chem; 2016 Oct; 68():259-64. PubMed ID: 27611728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Halogen bond tunability I: the effects of aromatic fluorine substitution on the strengths of halogen-bonding interactions involving chlorine, bromine, and iodine.
    Riley KE; Murray JS; Fanfrlík J; Rezáč J; Solá RJ; Concha MC; Ramos FM; Politzer P
    J Mol Model; 2011 Dec; 17(12):3309-18. PubMed ID: 21369930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some measures for making halogen bonds stronger than hydrogen bonds in H2CS-HOX (X = F, Cl, and Br) complexes.
    Li QZ; Jing B; Li R; Liu ZB; Li WZ; Luan F; Cheng JB; Gong BA; Sun JZ
    Phys Chem Chem Phys; 2011 Feb; 13(6):2266-71. PubMed ID: 21125096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Halogen bonds involved in binding of halogenated ligands by protein kinases.
    Poznański J; Winiewska M; Czapinska H; Poznańska A; Shugar D
    Acta Biochim Pol; 2016; 63(2):203-14. PubMed ID: 27104680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular conversion of MIG6 hotspot-3 peptide from the nonbinder to a moderate binder of HER2 by rational design of an orthogonal interaction system at the HER2-peptide interface.
    Zhang A; Liu P; Dou C; Liu Y; Che L
    Biophys Chem; 2021 Sep; 276():106625. PubMed ID: 34077816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Halogen as halogen-bonding donor and hydrogen-bonding acceptor simultaneously in ring-shaped H3N·X(Y)·HF (X = Cl, Br and Y = F, Cl, Br) complexes.
    Zhou PP; Qiu WY; Liu S; Jin NZ
    Phys Chem Chem Phys; 2011 Apr; 13(16):7408-18. PubMed ID: 21423995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of aldose reductase inhibition by halogen bond tuning.
    Fanfrlík J; Kolář M; Kamlar M; Hurný D; Ruiz FX; Cousido-Siah A; Mitschler A; Rezáč J; Munusamy E; Lepšík M; Matějíček P; Veselý J; Podjarny A; Hobza P
    ACS Chem Biol; 2013 Nov; 8(11):2484-92. PubMed ID: 23988122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonbonding interactions of organic halogens in biological systems: implications for drug discovery and biomolecular design.
    Lu Y; Wang Y; Zhu W
    Phys Chem Chem Phys; 2010 May; 12(18):4543-51. PubMed ID: 20428531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of halogen- and hydrogen-bond interactions between benzene derivatives and dimethyl sulfoxide.
    Zheng YZ; Deng G; Zhou Y; Sun HY; Yu ZW
    Chemphyschem; 2015 Aug; 16(12):2594-601. PubMed ID: 26118800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Halogen bonding in DNA base pairs.
    Parker AJ; Stewart J; Donald KJ; Parish CA
    J Am Chem Soc; 2012 Mar; 134(11):5165-72. PubMed ID: 22364257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calmodulin-dependent protein kinase II, and not protein kinase C, is sufficient for triggering cell-cycle resumption in mammalian eggs.
    Madgwick S; Levasseur M; Jones KT
    J Cell Sci; 2005 Sep; 118(Pt 17):3849-59. PubMed ID: 16091425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Halogen bonding for rational drug design and new drug discovery.
    Lu Y; Liu Y; Xu Z; Li H; Liu H; Zhu W
    Expert Opin Drug Discov; 2012 May; 7(5):375-83. PubMed ID: 22462734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based improvement of the binding affinity and recognition specificity of peptide competitors to target pediatric IL-5R/IL-5 interaction by gluing halogen bonds at their complex interface.
    Chu P; Sheng Y; Shen C; Xia Y; Kong L; Sun J
    J Mol Recognit; 2024 Mar; 37(2):e3070. PubMed ID: 37990248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational modification of the hierarchy of intermolecular interactions in molecular crystal structures by using tunable halogen bonds.
    Mínguez Espallargas G; Zordan F; Arroyo Marín L; Adams H; Shankland K; van de Streek J; Brammer L
    Chemistry; 2009 Aug; 15(31):7554-68. PubMed ID: 19593826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.